ஜாங் ஹில்ஹவுஸ் மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜாங் ஹில்ஹவுஸ் மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜாங் ஹில்ஹவுஸ் மூலதனம் Today - Breaking & Trending Today

Were Hedge Funds Right About Selling Kodiak Sciences Inc (KOD)?


Were Hedge Funds Right About Selling Kodiak Sciences Inc (KOD)?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow nearly 900 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are collectively bullish on. One of their picks is Kodiak Sciences Inc (NASDAQ:KOD), so let’s take a closer look at the sentiment that surrounds it in the current quarter.
Kodiak Sciences Inc (NASDAQ:KOD) has seen a decrease in enthusiasm from smart money in recent months. Kodiak Sciences Inc (NASDAQ:KOD) was in 17 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic is 20. There were 20 hedge funds in our database with KOD positions at the end of the fourth quarter. Our calculations also showed that KOD isn’t among ....

Felix Baker , Jim Cramer , Jamese Flynn Deerfield , John Osterweis , Bob Peck , Julian Baker , Shoals Technologies Group Inc , Amkor Technology Inc , Corelogic Inc , Regal Beloit Corporation , Systems Inc , Exchange Commission , Oneconnect Financial Technology Co Ltd , Pilgrim Pride Corporation , Kodiak Sciences Inc , Hedge Funds , Sciences Inc , Zhang Hillhouse Capital , Lei Zhang , Hillhouse Capital , Insider Monkey , Good Stock To Buy , Hillhouse Capital Management , Joseph Edelman , Perceptive Advisors , Andy Raab ,

Were Hedge Funds Right About Beam Therapeutics Inc. (BEAM)?


Were Hedge Funds Right About Beam Therapeutics Inc. (BEAM)?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we’ve gathered as a result gives us access to a wealth of collective knowledge based on these firms’ portfolio holdings as of March 31st. In this article, we will use that wealth of knowledge to determine whether or not Beam Therapeutics Inc. (NASDAQ:BEAM) makes for a good investment right now.
Beam Therapeutics Inc. (NASDAQ:BEAM) investors should pay attention to an increase in hedge fund interest lately. Beam Therapeutics Inc. (NASDAQ:BEAM) was in 18 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic was previously 14. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that BEAM isn’t among the 30 most popul ....

Jim Cramer , Alan Howard Brevan , Allogene Therapeutics Inc , Beam Therapeutics Inc , Redmile Group , Bearings Incorporated , Emergent Biosolutions Inc , Webster Financial Corporation , Cirrus Logic Inc , United Bankshares Inc , Beam Therapeutics , Zhang Hillhouse Capital , Lei Zhang , Hillhouse Capital , Insider Monkey , Good Stock To Buy , Capital Management , Casdin Capital , Farallon Capital , Perceptive Advisors , Renaissance Technologies , Jim Simons , Euclidean Capital , Alan Howard , United Bankshares , Allogene Therapeutics ,